MedPlus, Inc. Shareholders Approve Merger with Quest Diagnostics Incorporated.

CINCINNATI, Oct. 24 /PRNewswire/ --

MedPlus, Inc. announced today that its shareholders, during the Company's annual meeting held October 18, 2001, voted to approve the previously announced merger of MedPlus with Quest Diagnostics Incorporated.

(Photo: http://www.newscom.com/cgi-bin/prnh/19990901/MEDPLUSLOGO )

The closing of the merger, which remains subject to various customary conditions, has been tentatively scheduled for November 1, 2001. Following the closing, MedPlus will be a wholly owned subsidiary of Quest Diagnostics.

Richard A. Mahoney, Chairman of the Board and CEO of MedPlus, stated, "We are pleased and gratified that our shareholders voted to approve the merger, and we are eagerly anticipating the completion of this transaction."

About MedPlus

MedPlus(R) (Nasdaq: MEDP) is a leading developer and integrator of clinical connectivity and data management solutions for healthcare organizations and clinicians. These solutions efficiently and securely collect, store, manage and retrieve clinical information within an organization, enterprise or community via virtual private networks and/or the Internet. MedPlus solutions, including eMaxx(TM) (physician-focused clinical integration portal solution), ChartMaxx(TM) (electronic patient record solution) and OptiMaxx(R) (records storage and retrieval solution) have been implemented in more than 125 hospitals throughout North America. For more information, visit the Company's Web site at www.medplus.com .

MAKE YOUR OPINION COUNT - Click Here

http://tbutton.prnewswire.com/prn/11690X14957384